Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGLEC7 | Q9Y286 | 6/20 | 0.56 |
| ▸ | SELP | P16109 | 7/20 | 0.51 |
| ▸ | MAG | P20916 | 4/20 | 0.50 |
| ▸ | SELL | P14151 | 2/20 | 0.50 |
| ▸ | SELE | P16581 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30649207 | 1.00 | SIGLEC7 (0.56) | SIGLEC7SELPMAGSELLSELE | |
| SCHEMBL29369094 | 1.00 | SIGLEC7 (0.56) | SIGLEC7SELPMAGSELLSELE | |
| SCHEMBL30649952 | 1.00 | SIGLEC7 (0.56) | SIGLEC7SELPMAGSELLSELE | |
| SCHEMBL30650122 | 1.00 | SIGLEC7 (0.56) | SIGLEC7SELPMAGSELLSELE | |
| SCHEMBL30651291 | 1.00 | SIGLEC7 (0.56) | SIGLEC7SELPMAGSELLSELE | |
| SCHEMBL30651920 | 1.00 | SIGLEC7 (0.56) | SIGLEC7SELPMAGSELLSELE | |
| SCHEMBL31126371 | 1.00 | SIGLEC7 (0.56) | SIGLEC7SELPMAGSELLSELE | |
| SCHEMBL20971391 | 1.00 | SIGLEC7 (0.56) | SIGLEC7SELPMAGSELLSELE | |
| SCHEMBL22969674 | 1.00 | SIGLEC7 (0.56) | SIGLEC7SELPMAGSELLSELE | |
| SCHEMBL30650374 | 1.00 | SIGLEC7 (0.56) | SIGLEC7SELPMAGSELLSELE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 220 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4591933-A2 | TREATMENT OF AUTONOMIC DISORDERS | Ipsen Biopharm Limited (GB) | 2025-07-30 | — | — | EP | claimed |
| CN-120161518-A | Depth domain time-lapse seismic joint inversion method, device, equipment and storage medium | 中国石油天然气集团有限公司 | 2025-06-17 | — | — | CN | claimed |
| EP-3727429-B1 | TREATMENT OF AUTONOMIC DISORDERS WITH BOTULINUM TOXIN | IPSEN BIOPHARM LTD (GB) | 2025-05-07 | — | — | EP | claimed |
| CN-114596622-B | Iris and periocular countermeasure self-adaptive fusion recognition method based on comparison knowledge driving | 吉林大学 | 2025-04-04 | — | — | CN | claimed |
| US-20250034195-A1 | METHOD FOR THE PRODUCTION OF SPHINGOLIPIDS | CARBOCODE S.A. (PT) | 2025-01-30 | — | — | US | claimed |
| US-20240301178-A1 | POLYSACCHARIDE COMPLEX | ACARYON GMBH (DE) | 2024-09-12 | — | — | US | claimed |
| CN-114931630-B | Ganglioside composition for subcutaneous injection and application thereof | 齐鲁制药有限公司 | 2024-08-30 | — | — | CN | claimed |
| CN-118557903-A | Programmable weak charge generating device, generating method and related equipment | 迈胜医疗设备有限公司 | 2024-08-30 | — | — | CN | claimed |
| CN-118072114-B | Crack detection model, method and system based on impulse neural network | 合肥工大共达工程检测试验有限公司 | 2024-07-12 | — | — | CN | claimed |
| CN-118072114-A | Crack detection model, method and system based on impulse neural network | 合肥工大共达工程检测试验有限公司 | 2024-05-24 | — | — | CN | claimed |
| EP-4014039-A1 | CELLS HIGHLY SENSITIVE TO CLOSTRIDIAL NEUROTOXIN | Synaptic Research, LLC (US) | 2022-06-22 | — | — | EP | claimed |
| CN-114596622-A | Iris and periocular antagonism adaptive fusion recognition method based on contrast knowledge drive | 吉林大学 | 2022-06-07 | — | — | CN | claimed |
| CN-114555787-A | Genetically engineered cells sensitive to clostridial neurotoxins | 益普生生物制药有限公司 | 2022-05-27 | — | — | CN | claimed |
| CN-114527099-A | Methods for identifying pathways and insemination periods for achieving fertilization in mammals | 安卓威尔生命科学有限责任公司 | 2022-05-24 | — | — | CN | claimed |
| CN-110995961-B | Method and system for enhancing camera vignetting | 安徽清新互联信息科技有限公司 | 2022-04-19 | — | — | CN | claimed |
| CN-114337603-A | Four-order current type elliptic filter structure based on OTA-C | 中南民族大学 | 2022-04-12 | — | — | CN | claimed |
| CN-114157255-A | Multistage cascade broadband variable gain amplifier and in-band adjusting method thereof | 西北工业大学 | 2022-03-08 | — | — | CN | claimed |
| CN-114157256-A | Broadband programmable gain amplifier with high-precision dB linear characteristic | 西北工业大学 | 2022-03-08 | — | — | CN | claimed |
| CN-114072082-A | CAP-SCORETMUse in the identification of the reproductive pathway of males with varicoceles | 安卓威尔生命科学有限责任公司 | 2022-02-18 | — | — | CN | claimed |
| CN-108700494-B | Methods for identifying pathways and insemination periods for achieving fertilization in mammals | 安卓威尔生命科学有限责任公司 | 2022-02-11 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240301178-A1 | POLYSACCHARIDE COMPLEX | SGMS1, UGCG, SGMS2 | SIGLEC7 64/4885SELP 241/4885MAG 181/4885 |
| US-20250034195-A1 | METHOD FOR THE PRODUCTION OF SPHINGOLIPIDS | SGMS2, CERT1, SPTLC2 | SIGLEC7 507/4885SELP 2960/4885MAG 137/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.